Article info

Download PDFPDF
Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere

Authors

  1. Correspondence to Dr Richard Pebody, Respiratory Diseases Department, National Infection Service, Public Health England, 61 Colindale Avenue, London, UK; Richard.Pebody{at}phe.gov.uk
View Full Text

Citation

Pebody R, McMenamin J, Nohynek H
Live attenuated influenza vaccine (LAIV): recent effectiveness results from the USA and implications for LAIV programmes elsewhere

Publication history

  • Received March 1, 2017
  • Revised July 14, 2017
  • Accepted July 19, 2017
  • First published August 30, 2017.
Online issue publication 
December 13, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.